HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (41) Citing Articles via Google Scholar Google Scholar Articles by de Kok, J. B. Articles by Swinkels, D. W. Search for Related Content PubMed PubMed Citation Articles by de Kok, J. B. Articles by Swinkels, D. W. Related Collections Molecular Diagnostics and Genetics Proteomics and Protein Markers

Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues

Departments of
¹ Clinical Chemistry,
² Surgery,
³ Pathology, and
⁴ Urology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
^a Author for correspondence. Fax 31-243541743; e-mail J.dekok{at}ckcl.azn.nl

Background: Expression of the hTERT gene, which codes for the catalytic subunit of telomerase, is associated with malignancy. We recently developed a real-time reverse transcription-PCR assay, based on TaqMan technology, for accurate and reproducible determination of hTERT mRNA expression (Lab Investig 1999;79:911–2). This method may be of interest for molecular tumor diagnostics in tissues and corresponding body fluids, washings, or brushes.

Methods: In this study, we measured hTERT expression in a subset of healthy tissues and tumors to select those tumor types with the best potential for quantification of hTERT in corresponding body fluids. To demonstrate the use of the method in body fluids, we quantified hTERT expression in voided urine of patients with bladder cancer and controls.

Results: Real-time measurement of hTERT expression could discriminate between all healthy and malignant tissue samples from pancreas, lung, esophagus, and bladder, but not for colon tissues. Moreover, in five of nine (55%) urine samples, hTERT could be quantified.

Conclusions: The present study demonstrates that accurate quantitative measurement of hTERT expression has high potential for discrimination between healthy and tumor cells in tissues and urine and supports future measurements in pancreatic fluid, bronchoalveolar lavage fluid, esophageal brushings, and urine or bladder washings.

The following articles in journals at HighWire Press have cited this article:

				A. Webb, A. Johnson, M. Fortunato, A. Platt, T. Crabbe, M. I. Christie, G. F. Watt, S. G. Ward, and L. A. Jopling Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists J. Leukoc. Biol., October 1, 2008; 84(4): 1202 - 1212. [Abstract] [Full Text] [PDF]

				M. Hanke, I. Kausch, G. Dahmen, D. Jocham, and J. M. Warnecke Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer Clin. Chem., December 1, 2007; 53(12): 2070 - 2077. [Abstract] [Full Text] [PDF]

				B Luzar, M Poljak, A Cor, U Klopcic, and V Ferlan-Marolt Expression of human telomerase catalytic protein in gallbladder carcinogenesis J. Clin. Pathol., August 1, 2005; 58(8): 820 - 825. [Abstract] [Full Text] [PDF]

				R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]

				A. Tchirkov, C. Chaleteix, C. Magnac, Y. Vasconcelos, F. Davi, A. Michel, F. Kwiatkowski, O. Tournilhac, G. Dighiero, and P. Travade hTERT expression and prognosis in B-chronic lymphocytic leukemia Ann. Onc., October 1, 2004; 15(10): 1476 - 1480. [Abstract] [Full Text] [PDF]

				R. Gertler, R. Rosenberg, D. Stricker, J. Friederichs, A. Hoos, M. Werner, K. Ulm, B. Holzmann, H. Nekarda, and J.-R. Siewert Telomere Length and Human Telomerase Reverse Transcriptase Expression As Markers for Progression and Prognosis of Colorectal Carcinoma J. Clin. Oncol., May 15, 2004; 22(10): 1807 - 1814. [Abstract] [Full Text] [PDF]

				A. Stahlberg, J. Hakansson, X. Xian, H. Semb, and M. Kubista Properties of the Reverse Transcription Reaction in mRNA Quantification Clin. Chem., March 1, 2004; 50(3): 509 - 515. [Abstract] [Full Text] [PDF]

				F. Buttitta, C. Pellegrini, A. Marchetti, A. Gadducci, S. Cosio, L. Felicioni, F. Barassi, S. Salvatore, C. Martella, G. Coggi, et al. Human Telomerase Reverse Transcriptase mRNA Expression Assessed by Real-Time Reverse Transcription Polymerase Chain Reaction Predicts Chemosensitivity in Patients With Ovarian Carcinoma J. Clin. Oncol., April 1, 2003; 21(7): 1320 - 1325. [Abstract] [Full Text] [PDF]

				T. Masui, R. Hosotani, S. Tsuji, Y. Miyamoto, S. Yasuda, J. Ida, S. Nakajima, M. Kawaguchi, H. Kobayashi, M. Koizumi, et al. Expression of METH-1 and METH-2 in Pancreatic Cancer Clin. Cancer Res., November 1, 2001; 7(11): 3437 - 3443. [Abstract] [Full Text] [PDF]

eLetters: